New Pacific Metals C (NUXFF) 0.2510 $NUXFF New Pacific

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
New Pacific Metals C (NUXFF) 0.2510 $NUXFF

New Pacific Reports Financial Results for the Three and Nine Months Ended March 31, 2016
Marketwire Canada - Fri May 13, 4:00PM CDT
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 13, 2016) - New Pacific Metals Corp. ("New Pacific" or the "Company" (TSX:NUX) today announced its unaudited condensed consolidated interim financial results for the three and nine months ended March 31, 2016.
NUX.TO: 0.34 (-0.01)

New Pacific Reports Financial Results for the Three Months Ended September 30, 2015
Marketwired - Mon Nov 16, 3:31PM CST
New Pacific Metals Corp. (TSX: NUX) ("New Pacific" or the "Company" today announced its unaudited condensed consolidated interim financial results for the three months ended September 30, 2015.
NUX.TO: 0.34 (-0.01)

New Pacific Reports 2015 Annual General and Special Meeting Results
Marketwired - Mon Nov 16, 3:24PM CST
New Pacific Metals Corp. ("New Pacific" or the "Company" (TSX: NUX) is pleased to report that all matters submitted to the shareholders for approval as set out in the Company's Notice of Meeting and Information Circular, both dated October 9, 2015, were approved by the requisite majority of votes cast at the annual general and special meeting of the shareholders held on November 13, 2015 (the "AGM".
NUX.TO: 0.34 (-0.01)

IIROC Trade Resumption - New Pacific Metals Corp.
Newsfile Corp - Thu Oct 29, 11:52AM CDT
Trading resumes in:

IIROC Trade Halt - New Pacific Metals Corp.
Newsfile Corp - Thu Oct 29, 11:42AM CDT
The following issues have been halted by IIROC:

New Pacific Annual General and Special General Meeting on November 13, 2015
Marketwired - Thu Oct 29, 11:38AM CDT
NEW PACIFIC METALS CORP. (TSX: NUX) ("New Pacific" or the "Company" is pleased to announce that it will hold its annual general and special general meeting of its shareholders on November 13, 2015, (the "AGM".
NUX.TO: 0.34 (-0.01)

New Pacific Reports Financial Results for the Year Ended June 30, 2015
Marketwired - Wed Sep 16, 4:59PM CDT
New Pacific Metals Corp. (TSX: NUX) ("New Pacific" or the "Company" today announced its audited consolidated financial results for the year ended June 30, 2015.
NUX.TO: 0.34 (-0.01)

New Pacific Reports Financial Results for the Three and Six Months Ended December 31, 2014-Appoints Chief Financial Officer
Marketwire Canada - Mon Feb 16, 3:30PM CST
New Pacific Metals Corp. ("New Pacific" or the "Company" (TSX:NUX) today announced its unaudited condensed consolidated interim financial results for the three and six months ended December 31, 2014.
NUX.TO: 0.34 (-0.01)

New Pacific Reports 2014 AGM Results
Marketwired - Wed Dec 03, 5:43PM CST
New Pacific Metals Corp. ("New Pacific" or the "Company" (TSX: NUX) is pleased to report that all matters placed before the shareholders at its Annual General held on December 1, 2014, were approved. The voting report of the Annual General Meeting is available for review on SEDAR.
NUX.TO: 0.34 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

IMCD Expands Reach in Latin America with Blumos Acquisition

Updated Category News Views 88

IMCD Expands Reach in Latin America with Blumos Acquisition IMCD N.V. is making significant strides in the life science markets across Latin America through its recent acquisition of the Blumos Group. This move showcases IMCD's commitment to growing its footprint in the region, enhancing its distribution of specialty chemicals and ingredients. About Blumos Group Founded...

Continue Reading
Insights on the Recent Decline of SolarEdge Technologies (SEDG)

Updated Category News Views 129

Understanding the Decline of SolarEdge Technologies SolarEdge Technologies Inc (NASDAQ: SEDG) recently faced a notable decline in its stock price, falling by 5.47% to $17.96. This drop is part of a broader downward trend affecting clean energy stocks, triggered by concerns surrounding the pricing strategies and performance expectations of major players in the solar energy...

Continue Reading
FCP Secures $16.7M for Multifamily Project in Lake Nona

Updated Category News Views 191

FCP Closes $16.7 Million for Royal Palm at Nona Development FCP has announced a significant milestone by closing a $16.7 million preferred equity investment aimed at financing the Royal Palm at Nona project. This 320-unit, Class A multifamily development is set to rise in a rapidly growing submarket. The development is spearheaded by Royal Palm Companies, a reputable firm...

Continue Reading
TeamLinkt Receives Growth Investment to Expand AI Sports Platform

Updated Category News Views 318

TeamLinkt Gains Momentum with Strategic Investment TeamLinkt, a groundbreaking sports management platform, proudly announces a significant minority growth investment from Growth Street Partners. This investment marks an exciting chapter for TeamLinkt as it aims to enhance its technology and expand support services for sports leagues, clubs, and associations....

Continue Reading
Glucose Health Validates Fiber's Importance for Public Well-Being

Updated Category News Views 102

Glucose Health, Inc. Shines a Light on Dietary Fiber's Importance In an important recognition, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) have identified dietary fiber as a nutrient of public health concern. This announcement holds significant weight for Glucose Health, Inc. (OTC: GLUC), a leader in diabetic...

Continue Reading